RENAISSANCE TECHNOLOGIES LLC
Institutional investor · Portfolio as of Q4 2019
Top Holdings3,469 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
BRISTOL-MYERS SQUIBB CO | 60.2M | $3.9B | 3.0% | $49.58 | 0.00% | 1 qtr | New 83 |
TESLA INC | 3.9M | $1.6B | 1.3% | $27.65 | 0.00% | 1 qtr | New 73 |
VERISIGN INC | 8.3M | $1.6B | 1.2% | $190.67 | 0.00% | 1 qtr | New 73 |
VERTEX PHARMACEUTICALS INC | 7.1M | $1.5B | 1.2% | $218.97 | 0.00% | 1 qtr | New 73 |
NOVO-NORDISK A/S-SPONS ADR | 26.2M | $1.5B | 1.2% | $25.93 | 0.00% | 1 qtr | New 73 |
CHIPOTLE MEXICAN GRILL INC | 1.8M | $1.5B | 1.1% | $16.72 | 0.00% | 1 qtr | New 73 |
BIOGEN IDEC INC | 4.6M | $1.4B | 1.0% | $296.73 | 0.00% | 1 qtr | New 73 |
PALO ALTO NETWORKS INC | 5.7M | $1.3B | 1.0% | $38.57 | 0.00% | 1 qtr | New 73 |
GILEAD SCIENCES INC | 17M | $1.1B | 0.8% | $51.50 | 0.00% | 1 qtr | New 62 |
HUMANA INC | 3M | $1.1B | 0.8% | $348.89 | 0.00% | 1 qtr | New 62 |
WALMART INC | 8.9M | $1.1B | 0.8% | $36.57 | 0.00% | 1 qtr | New 62 |
ABBVIE INC | 11.8M | $1B | 0.8% | $68.47 | 0.00% | 1 qtr | New 62 |
ALLERGAN PLC | 5M | $959.6M | 0.7% | — | — | 1 qtr | New 62 |
PETROLEO BRASILEIRO-SPON ADR | 56.7M | $903.7M | 0.7% | $4.80 | 0.00% | 1 qtr | New 62 |
| 19M | $894.1M | 0.7% | — | — | 1 qtr | New 62 | |
GENERAL ELECTRIC CO | 75.6M | $844M | 0.6% | — | — | — | — |
AMGEN INC | 3.2M | $761.7M | 0.6% | $198.37 | 0.00% | 1 qtr | New 62 |
| 6.1M | $731.9M | 0.6% | — | — | 1 qtr | New 62 | |
ALIGN TECHNOLOGY INC | 2.6M | $728.5M | 0.6% | $275.63 | 0.00% | 1 qtr | New 62 |
MONSTER BEVERAGE CORP | 11.5M | $727.8M | 0.6% | $31.78 | 0.00% | 1 qtr | New 62 |
RENAISSANCE TECHNOLOGIES LLC manages $130.1B across 3469 positions as of Q4 2019. Top holdings: BMY (3.0%), TSLA (1.3%), VRSN (1.2%). Fund DNA: Diversified Scout. HoldingsIntel Rating: 2.5/5.0.
Active quarter - 3467 new positions, 0 exits, 0 increased. Top move: BMY (NEW, conviction 83). Portfolio: $130.1B across 3469 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer